Trade DOCMORRIS AG ORD - DOCM CFD
Add to favourite- Summary
- Historical Data
- Events
- Income Statement
- Balance Sheet
- Cash Flow
- Ownership
Spread | 1.55 | ||||||||
Long position overnight fee
Long position overnight fee
Go to platform | -0.015687% | ||||||||
Short position overnight fee
Short position overnight fee
Go to platform | -0.006535% | ||||||||
Overnight fee time | 22:00 (UTC) | ||||||||
Min traded quantity | 1 | ||||||||
Currency | CHF | ||||||||
Margin | 5% | ||||||||
Stock exchange | Switzerland | ||||||||
Commission on trade | 0% |
*Information provided by Capital.com
DocMorris AG ESG Risk Ratings
‘B’ score indicates good relative ESG performance and above average degree of transparency in reporting material ESG data publicly.
Prev. Close* | 58.4 |
Open* | 57.95 |
1-Year Change* | 143.49% |
Day's Range* | 57.75 - 62.3 |
52 wk Range | 23.58-75.00 |
Average Volume (10 days) | 99.12K |
Average Volume (3 months) | 2.15M |
Market Cap | 700.10M |
P/E Ratio | -100.00K |
Shares Outstanding | 11.76M |
Revenue | 1.25B |
EPS | -12.60 |
Dividend (Yield %) | N/A |
Beta | 1.10 |
Next Earnings Date | Mar 21, 2024 |
All data is provided by Refinitiv, except for data marked with an asterisk, which is *data provided by Capital.com
- Last Week
- Last Month
- Last Year
- Last two Years
- Max
- Daily
- Weekly
- Monthly
Date | Close | Change | Change (%) | Open | High | Low |
---|---|---|---|---|---|---|
Nov 29, 2023 | 58.40 | 3.80 | 6.96% | 54.60 | 58.65 | 54.60 |
Nov 28, 2023 | 54.80 | 2.40 | 4.58% | 52.40 | 55.90 | 51.90 |
Nov 27, 2023 | 52.35 | -0.55 | -1.04% | 52.90 | 55.45 | 51.45 |
Nov 24, 2023 | 53.35 | 1.00 | 1.91% | 52.35 | 53.40 | 51.55 |
Nov 23, 2023 | 53.20 | 3.35 | 6.72% | 49.85 | 53.65 | 49.55 |
Nov 22, 2023 | 50.70 | 0.75 | 1.50% | 49.95 | 51.90 | 48.40 |
Nov 21, 2023 | 49.60 | -4.40 | -8.15% | 54.00 | 54.00 | 48.90 |
Nov 20, 2023 | 53.80 | 2.55 | 4.98% | 51.25 | 54.00 | 51.20 |
Nov 17, 2023 | 51.45 | 2.40 | 4.89% | 49.05 | 51.65 | 48.65 |
Nov 16, 2023 | 49.75 | 2.10 | 4.41% | 47.65 | 49.95 | 47.65 |
Nov 15, 2023 | 48.80 | -1.25 | -2.50% | 50.05 | 51.50 | 48.25 |
Nov 14, 2023 | 48.70 | 5.85 | 13.65% | 42.85 | 49.55 | 42.65 |
Nov 13, 2023 | 42.20 | -1.45 | -3.32% | 43.65 | 44.15 | 41.25 |
Nov 10, 2023 | 42.60 | -0.60 | -1.39% | 43.20 | 44.35 | 42.10 |
Nov 9, 2023 | 44.00 | 5.30 | 13.70% | 38.70 | 44.15 | 38.70 |
Nov 8, 2023 | 38.25 | 0.30 | 0.79% | 37.95 | 39.25 | 37.95 |
Nov 7, 2023 | 38.85 | 1.15 | 3.05% | 37.70 | 39.20 | 37.70 |
Nov 6, 2023 | 37.65 | -0.25 | -0.66% | 37.90 | 38.40 | 37.35 |
Nov 3, 2023 | 38.25 | 0.15 | 0.39% | 38.10 | 39.15 | 37.85 |
Nov 2, 2023 | 37.70 | 0.30 | 0.80% | 37.40 | 39.35 | 37.15 |
DOCMORRIS AG ORD Events
Time (UTC) | Country | Event |
---|---|---|
Thursday, March 21, 2024 | ||
Time (UTC) 10:00 | Country CH
| Event Full Year 2023 DocMorris AG Earnings Call Full Year 2023 DocMorris AG Earnings CallForecast -Previous - |
Time (UTC) 10:59 | Country CH
| Event Full Year 2023 Zur Rose Group AG Earnings Release Full Year 2023 Zur Rose Group AG Earnings ReleaseForecast -Previous - |
- Annual
- Quarterly
2022 | 2021 | 2020 | 2019 | 2018 | |
---|---|---|---|---|---|
Total revenue | 1608.22 | 1726.5 | 1476.93 | 1355.54 | 1207.11 |
Revenue | 1608.22 | 1726.5 | 1476.93 | 1355.54 | 1207.11 |
Cost of Revenue, Total | 1362.59 | 1460.38 | 1227.95 | 1146.7 | 1015.64 |
Gross Profit | 245.627 | 266.126 | 248.98 | 208.839 | 191.464 |
Total Operating Expense | 1746 | 1920.28 | 1594.56 | 1401.24 | 1238.51 |
Selling/General/Admin. Expenses, Total | 327.874 | 379.513 | 308.438 | 251.492 | 165.824 |
Depreciation / Amortization | 54.882 | 50.437 | 38.616 | 31.149 | 19.13 |
Unusual Expense (Income) | 3.907 | 3.962 | 8.282 | -17.499 | -0.016 |
Other Operating Expenses, Total | -3.259 | 25.991 | 11.277 | -10.598 | 37.926 |
Operating Income | -137.777 | -193.777 | -117.633 | -45.705 | -31.4 |
Interest Income (Expense), Net Non-Operating | -30.961 | -31.655 | -14.557 | -3.789 | -6.722 |
Other, Net | -1.131 | -1.252 | -1.019 | -0.617 | -0.425 |
Net Income Before Taxes | -169.869 | -226.684 | -133.209 | -50.111 | -38.547 |
Net Income After Taxes | -171.115 | -225.735 | -135.644 | -52.376 | -39.1 |
Net Income Before Extra. Items | -171.115 | -225.735 | -135.695 | -52.358 | -38.971 |
Net Income | -171.115 | -225.735 | -135.695 | -52.358 | -38.971 |
Income Available to Common Excl. Extra. Items | -171.115 | -225.735 | -135.695 | -52.358 | -38.971 |
Income Available to Common Incl. Extra. Items | -171.115 | -225.735 | -135.695 | -52.358 | -38.971 |
Diluted Net Income | -171.115 | -225.735 | -135.695 | -52.358 | -38.971 |
Diluted Weighted Average Shares | 10.7752 | 9.64538 | 9.07641 | 8.66449 | 6.34864 |
Diluted EPS Excluding Extraordinary Items | -15.8804 | -23.4034 | -14.9503 | -6.04282 | -6.13848 |
Diluted Normalized EPS | -14.0974 | -22.1385 | -10.9801 | -7.35558 | -6.14012 |
Minority Interest | 0 | -0.051 | 0.018 | 0.129 | |
Dividends per Share - Common Stock Primary Issue | 0 | 0 | 0 | 0 | 0 |
Jun 2023 | Dec 2022 | Jun 2022 | Dec 2021 | Jun 2021 | |
---|---|---|---|---|---|
Total revenue | 462.957 | 784.258 | 494.645 | 886.715 | 839.788 |
Revenue | 462.957 | 784.258 | 494.645 | 886.715 | 839.788 |
Cost of Revenue, Total | 363.021 | 659.354 | 414.864 | 761.941 | 704.516 |
Gross Profit | 99.936 | 124.904 | 79.781 | 124.774 | 135.272 |
Total Operating Expense | 511.766 | 855.094 | 561.948 | 1007.38 | 912.897 |
Selling/General/Admin. Expenses, Total | 60.472 | 76.764 | 57.389 | 71.406 | 76.944 |
Depreciation / Amortization | 20.674 | 36.254 | 18.713 | 27.746 | 23.397 |
Other Operating Expenses, Total | 67.599 | 82.722 | 70.982 | 146.29 | 108.04 |
Operating Income | -48.809 | -70.836 | -67.303 | -120.668 | -73.109 |
Interest Income (Expense), Net Non-Operating | -9.473 | -12.204 | -16.898 | -28.218 | -4.689 |
Net Income Before Taxes | -58.282 | -83.04 | -84.201 | -148.886 | -77.798 |
Net Income After Taxes | -58.24 | -85.028 | -83.573 | -148.701 | -77.034 |
Minority Interest | 0 | 0 | |||
Net Income Before Extra. Items | -58.24 | -85.028 | -83.573 | -148.701 | -77.034 |
Net Income | 141.605 | -85.028 | -86.087 | -148.701 | -77.034 |
Income Available to Common Excl. Extra. Items | -58.24 | -85.028 | -83.573 | -148.701 | -77.034 |
Income Available to Common Incl. Extra. Items | 141.605 | -85.028 | -86.087 | -148.701 | -77.034 |
Diluted Net Income | 141.605 | -85.028 | -86.087 | -148.701 | -77.034 |
Diluted Weighted Average Shares | 11.6836 | 11.166 | 10.3844 | 9.69748 | 9.59328 |
Diluted EPS Excluding Extraordinary Items | -4.98477 | -7.6149 | -8.04791 | -15.334 | -8.03 |
Dividends per Share - Common Stock Primary Issue | 0 | 0 | 0 | 0 | 0 |
Diluted Normalized EPS | -4.57843 | -6.52801 | -6.79265 | -14.8655 | -7.50015 |
Total Extraordinary Items | 199.845 | -2.514 |
- Annual
- Quarterly
2022 | 2021 | 2020 | 2019 | 2018 | |
---|---|---|---|---|---|
Total Current Assets | 395.884 | 537.14 | 539.273 | 428.067 | 416.748 |
Cash and Short Term Investments | 156.402 | 278.202 | 300.972 | 204.906 | 230.846 |
Cash & Equivalents | 126.042 | 277.742 | 300.614 | 204.681 | 230.693 |
Short Term Investments | 30.36 | 0.46 | 0.358 | 0.225 | 0.153 |
Total Receivables, Net | 138.941 | 141.946 | 130.047 | 142.668 | 103.782 |
Accounts Receivable - Trade, Net | 129.351 | 131.962 | 114.948 | 126.721 | 92.311 |
Total Inventory | 83.18 | 92.464 | 92.941 | 70.608 | 69.4 |
Prepaid Expenses | 17.361 | 24.528 | 15.313 | 9.885 | 12.72 |
Total Assets | 1099.44 | 1269.21 | 1278.48 | 991.725 | 726.52 |
Property/Plant/Equipment, Total - Net | 96.808 | 98.703 | 96.579 | 77.127 | 34.294 |
Property/Plant/Equipment, Total - Gross | 162.741 | 156.567 | 156.401 | 130.844 | 86.091 |
Accumulated Depreciation, Total | -65.933 | -57.864 | -59.822 | -53.717 | -51.797 |
Goodwill, Net | 400.78 | 418.411 | 435.276 | 334.686 | 172.423 |
Intangibles, Net | 171.126 | 176.951 | 169.261 | 130.567 | 92.202 |
Long Term Investments | 3.569 | 6.332 | 7.478 | 7.193 | 1.333 |
Note Receivable - Long Term | 26.486 | 25.025 | 24.184 | 6.018 | 0.94 |
Other Long Term Assets, Total | 4.792 | 6.652 | 6.431 | 8.067 | 8.58 |
Total Current Liabilities | 241.349 | 212.537 | 156.658 | 212.596 | 118.967 |
Accounts Payable | 112.781 | 132.173 | 93.319 | 92.109 | 83.127 |
Payable/Accrued | 1.73 | 2.708 | |||
Accrued Expenses | 51.75 | 53.706 | 43.482 | 27.86 | 24.963 |
Notes Payable/Short Term Debt | 0 | 0 | 0 | 0 | 0 |
Current Port. of LT Debt/Capital Leases | 61.221 | 16.429 | 6.801 | 87.395 | 3.521 |
Other Current Liabilities, Total | 15.597 | 10.229 | 13.056 | 3.502 | 4.648 |
Total Liabilities | 748.666 | 784.291 | 746.741 | 586.073 | 282.944 |
Total Long Term Debt | 493.129 | 552.736 | 563.814 | 350.206 | 144.74 |
Long Term Debt | 460.203 | 518.173 | 527.658 | 313.755 | 142.827 |
Deferred Income Tax | 6.865 | 7.647 | 8.277 | 6.216 | 5.47 |
Other Liabilities, Total | 7.323 | 11.371 | 17.992 | 17.165 | 13.737 |
Total Equity | 350.779 | 484.923 | 531.741 | 405.652 | 443.576 |
Common Stock | 404.728 | 335.839 | 315.791 | 262.199 | 48.127 |
Retained Earnings (Accumulated Deficit) | 75.382 | 234.829 | 284.482 | 183.325 | 416.473 |
Treasury Stock - Common | -60.67 | -31.308 | -31.927 | -5.219 | -5.453 |
Other Equity, Total | -68.661 | -54.437 | -36.605 | -34.653 | -15.571 |
Total Liabilities & Shareholders’ Equity | 1099.44 | 1269.21 | 1278.48 | 991.725 | 726.52 |
Total Common Shares Outstanding | 11.5503 | 10.2469 | 9.57174 | 8.6821 | 8.30952 |
Minority Interest | 0 | -0.11 | 0.03 | ||
Additional Paid-In Capital | |||||
Capital Lease Obligations | 32.926 | 34.563 | 36.156 | 36.451 | 1.913 |
Jun 2023 | Dec 2022 | Jun 2022 | Dec 2021 | Jun 2021 | |
---|---|---|---|---|---|
Total Current Assets | 405.263 | 395.884 | 432.629 | 537.14 | 496.985 |
Cash and Short Term Investments | 282.078 | 156.402 | 199.682 | 278.202 | 252.002 |
Cash & Equivalents | 199.712 | 126.042 | 199.185 | 277.742 | 251.672 |
Short Term Investments | 82.366 | 30.36 | 0.497 | 0.46 | 0.33 |
Total Receivables, Net | 52.962 | 145.281 | 142.737 | 144.969 | 140.06 |
Accounts Receivable - Trade, Net | 44.177 | 129.351 | 127.159 | 131.962 | 124.887 |
Total Inventory | 43.657 | 83.18 | 70.414 | 92.464 | 83.931 |
Prepaid Expenses | 15.085 | 11.021 | 19.796 | 21.505 | 20.992 |
Total Assets | 1010.52 | 1099.44 | 1143.79 | 1269.21 | 1251.44 |
Property/Plant/Equipment, Total - Net | 71.096 | 96.808 | 96.383 | 98.703 | 99.098 |
Intangibles, Net | 519.809 | 571.906 | 580.777 | 595.362 | 616.962 |
Long Term Investments | 13.152 | 30.055 | 28.458 | 31.357 | 31.62 |
Other Long Term Assets, Total | 1.201 | 4.792 | 5.546 | 6.652 | 6.773 |
Total Current Liabilities | 147.134 | 241.349 | 193.029 | 212.537 | 190.744 |
Accounts Payable | 55.667 | 112.781 | 116.933 | 132.173 | 117.687 |
Accrued Expenses | 31.399 | 39.691 | 45.741 | 43.548 | 46.426 |
Notes Payable/Short Term Debt | 0 | 0 | 0 | 0 | 0 |
Current Port. of LT Debt/Capital Leases | 42.649 | 61.221 | 9.277 | 16.429 | 6.245 |
Other Current Liabilities, Total | 17.419 | 27.656 | 21.078 | 20.387 | 20.386 |
Total Liabilities | 516.457 | 748.666 | 744.729 | 784.291 | 785.298 |
Total Long Term Debt | 361.949 | 493.129 | 544.025 | 552.736 | 566.152 |
Long Term Debt | 334.185 | 460.203 | 511.913 | 518.173 | 529.568 |
Capital Lease Obligations | 27.764 | 32.926 | 32.112 | 34.563 | 36.584 |
Deferred Income Tax | 5.92 | 6.865 | 7.365 | 7.647 | 7.896 |
Other Liabilities, Total | 1.454 | 7.323 | 0.31 | 11.371 | 20.506 |
Total Equity | 494.064 | 350.779 | 399.064 | 484.923 | 466.14 |
Common Stock | 409.873 | 404.728 | 340.965 | 335.839 | 316.149 |
Retained Earnings (Accumulated Deficit) | 217.244 | 75.382 | 154.591 | 234.829 | 214.655 |
Treasury Stock - Common | -62.393 | -60.67 | -30.689 | -31.308 | -31.607 |
Other Equity, Total | -70.66 | -68.661 | -65.803 | -54.437 | -33.057 |
Total Liabilities & Shareholders’ Equity | 1010.52 | 1099.44 | 1143.79 | 1269.21 | 1251.44 |
Total Common Shares Outstanding | 11.6077 | 11.5503 | 10.2469 | 10.2469 | 9.57174 |
Other Current Assets, Total | 11.481 |
- Annual
- Quarterly
2022 | 2021 | 2020 | 2019 | 2018 | |
---|---|---|---|---|---|
Net income/Starting Line | -171.115 | -225.735 | -135.644 | -52.376 | -39.1 |
Cash From Operating Activities | -97.287 | -130.631 | -67.511 | -82.571 | -33.227 |
Cash From Operating Activities | 62.63 | 51.143 | 39.251 | 31.863 | 18.862 |
Non-Cash Items | 18.014 | 40.145 | 34.961 | -29.216 | 9.423 |
Cash Taxes Paid | 2.184 | 0.031 | 0.518 | 2.069 | 0.783 |
Cash Interest Paid | 15.989 | 14.438 | 12.265 | 4.018 | 1.698 |
Changes in Working Capital | -6.816 | 3.816 | -6.079 | -32.842 | -22.412 |
Cash From Investing Activities | -89.771 | -67.329 | -199.856 | -143.181 | -140.275 |
Capital Expenditures | -59.289 | -63.477 | -59.827 | -41.511 | -31.503 |
Other Investing Cash Flow Items, Total | -30.482 | -3.852 | -140.029 | -101.67 | -108.772 |
Cash From Financing Activities | 39.107 | 179.721 | 363.247 | 200.19 | 297.055 |
Total Cash Dividends Paid | |||||
Issuance (Retirement) of Stock, Net | 42.055 | 187.301 | 206.095 | 0.495 | 184.782 |
Issuance (Retirement) of Debt, Net | 0.506 | -7.58 | 157.895 | 200.009 | 112.273 |
Foreign Exchange Effects | -3.749 | -4.633 | 0.053 | -0.45 | -0.624 |
Net Change in Cash | -151.7 | -22.872 | 95.933 | -26.012 | 122.929 |
Financing Cash Flow Items | -3.454 | 0 | -0.743 | -0.314 |
Dec 2022 | Jun 2022 | Dec 2021 | Jun 2021 | |
---|---|---|---|---|
Net income/Starting Line | -171.115 | -86.087 | -225.735 | -77.034 |
Cash From Operating Activities | -97.287 | -40.236 | -130.631 | -16.351 |
Cash From Operating Activities | 62.63 | 26.376 | 51.143 | 23.397 |
Non-Cash Items | 18.014 | 6.299 | 40.145 | 10.169 |
Cash Taxes Paid | 2.184 | 0.668 | 0.031 | -0.04 |
Cash Interest Paid | 15.989 | 3.208 | 14.438 | 3.154 |
Changes in Working Capital | -6.816 | 13.176 | 3.816 | 27.117 |
Cash From Investing Activities | -89.771 | -29.661 | -67.329 | -31.311 |
Capital Expenditures | -59.289 | -30.04 | -63.477 | -30.015 |
Other Investing Cash Flow Items, Total | -30.482 | 0.379 | -3.852 | -1.296 |
Cash From Financing Activities | 39.107 | -5.698 | 179.721 | -2.527 |
Financing Cash Flow Items | -3.454 | -3.741 | 0 | 0.001 |
Issuance (Retirement) of Stock, Net | 42.055 | 0.899 | 187.301 | 0.806 |
Issuance (Retirement) of Debt, Net | 0.506 | -2.856 | -7.58 | -3.334 |
Foreign Exchange Effects | -3.749 | -2.962 | -4.633 | 1.247 |
Net Change in Cash | -151.7 | -78.557 | -22.872 | -48.942 |
Investor Name | Investor Type | Percent Outstanding | Shares Held | Shares change | Holdings Date | Turnover Rating |
---|---|---|---|---|---|---|
UBS Asset Management (Switzerland) | Investment Advisor | 16.503 | 2261015 | -7795 | 2023-10-17 | LOW |
Sands Capital Management, LLC | Investment Advisor | 4.432 | 607213 | 0 | 2022-12-31 | LOW |
PSquared Asset Management AG | Investment Advisor/Hedge Fund | 2.9792 | 408173 | 100000 | 2023-08-21 | HIGH |
BlackRock Institutional Trust Company, N.A. | Investment Advisor | 2.8568 | 391394 | -28790 | 2023-09-11 | LOW |
The Vanguard Group, Inc. | Investment Advisor/Hedge Fund | 1.785 | 244555 | 7013 | 2023-09-30 | LOW |
Credit Suisse Funds AG | Investment Advisor/Hedge Fund | 1.6043 | 219804 | 3810 | 2023-09-30 | LOW |
Zürcher Kantonalbank (Asset Management) | Bank and Trust | 1.3386 | 183391 | 2723 | 2023-09-30 | LOW |
Oberhaensli (Walter) | Individual Investor | 0.8238 | 112870 | 8608 | 2022-12-31 | |
Finreon AG | Investment Advisor | 0.7635 | 104602 | -6303 | 2023-07-31 | MED |
St. Galler Kantonalbank AG | Investment Advisor | 0.6554 | 89799 | 0 | 2022-10-31 | MED |
Capital Research Global Investors | Investment Advisor | 0.4624 | 63350 | 0 | 2023-09-30 | LOW |
Feuerstein (Stefan) | Individual Investor | 0.3859 | 52865 | 599 | 2022-12-31 | |
Ziwica (Marcel) | Individual Investor | 0.3272 | 44830 | 2079 | 2022-12-31 | |
Azimut Capital Management Sgr SpA | Investment Advisor/Hedge Fund | 0.3168 | 43400 | 0 | 2023-09-30 | HIGH |
BlackRock Advisors (UK) Limited | Investment Advisor/Hedge Fund | 0.3103 | 42515 | -72297 | 2023-09-30 | LOW |
Globalance Bank AG | Bank and Trust | 0.2931 | 40151 | 0 | 2023-09-30 | MED |
zCapital AG | Investment Advisor | 0.2744 | 37600 | -2400 | 2023-08-31 | LOW |
Pictet Asset Management Ltd. | Investment Advisor/Hedge Fund | 0.2647 | 36271 | 0 | 2023-06-30 | LOW |
Hess (Walter) | Individual Investor | 0.2622 | 35919 | 7746 | 2022-12-31 | |
Ethenea Independent Investors S.A. | Investment Advisor | 0.2577 | 35306 | 0 | 2023-09-30 | HIGH |
Trading calculator
Calculate your hypothetical P&L if you had opened a CFD trade on a certain date (select a date) and closed on a different date (select a date).
- 1:1
- 20
- 100
- 500
- 1000
- 10000
ZUR ROSE GROUP N Company profile
About Zur Rose Group AG
Zur Rose Group AG is a Switzerland-based company engaged in the drug distribution sector. The Company focuses on the wholesale trade of medicines, as well as operation of a mail-order pharmacy. The Company's activities are divided into two business segments: Zur Rose and DocMorris. The Zur Rose division includes wholesale business and provides drugs to medical doctors, health insurance companies, hospitals and healthcare companies, among others. The DocMorris division manages the mail-order business for drug retail. The Company operates in Switzerland, Germany and the Netherlands through a number of subsidiaries, such as Zur Rose Suisse AG, Zur Rose Pharma GmbH, BlueCare AG, DocMorris NV, Eurapon Pharmahandel GmbH and Vitalsana BV.
Financial summary
BRIEF: For the fiscal year ended 31 December 2021, Zur Rose Group AG revenues increased 17% to SF1.73B. Net loss increased 66% to SF225.7M. Revenues reflect Germany segment increase of 25% to SF1.02B, Switzerland segment increase of 5% to SF620.2M, Germany segment increase of 25% to SF1.02B, Switzerland segment increase of 5% to SF620.2M. Higher net loss reflects Marketing and acquisition expenses increase of 96% to SF118.8M (expense).
Equity composition
11/2018 rights issue, adj. fct. 1.05607, new shares offered 2665476 (late adjustment from e-mail)
Industry: | Drug Retailers (NEC) |
Walzmühlestrasse 49
FRAUENFELD
THURGAU 8500
CH
Income Statement
- Annual
- Quarterly
News

Euro Zone CPI expected to continue dropping; economists warn about cutting too soon
EZ PI expected to drop further but speed of decline
08:16, 29 November 2023
A weaker Dollar drives gold higher
Gold prices have returned above $US2000 per ounce. We run through the factors driving gold and the commodity’s key technicals.
13:49, 28 November 2023
Q3 US Earnings Recap: Profits surprise to the upside, but outlook remains uncertain
US earnings for the third quarter were far better than expected. However, uncertainty about the outlook for company profits continues. We review the quarterly earnings and look ahead to what the markets expect from S&P 500 companies going forward.
13:20, 28 November 2023
RBNZ Preview: Rates expected to remain unchanged at final meeting of 2023
The RBNZ meets for the final time this year on Wednesday, 29th of November, 2023. We preview what to expect and how it could impact the New Zealand Dollar.
13:04, 28 November 2023
Crude prices slide on OPEC+ uncertainty
Crude prices have chopped sideways amid signs of turmoil within OPEC+. We look at the fundamentals of the oil market and the technical levels of WTI.
12:55, 28 November 2023
UK AUTUMN BUDGET: Will Hunt cut taxes? How will GBP react this time around?
UK Chancellor Hunt will deliver the 2023 autumn statement to MPs on Wednesday 22 November.
10:48, 21 November 2023
Gold Rises as Traders price-in Fed Rate Cuts
Gold prices have declined despite a drop in Treasury yields and a weaker US Dollar. We look at the key drivers and technical levels for the gold price.
13:17, 20 November 2023People also watch
Still looking for a broker you can trust?
Join the 570.000+ traders worldwide that chose to trade with Capital.com